Submit Content
Get the latest delivered to your inbox
Privacy Policy

Illumina

Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. 

    How Illumina's Newest Employee Resource Group, iLatinx, Supports Employees and Advocates for Diversity in Life Science Image

    POSTED 

    10-10-22

    How Illumina's Newest Employee Resource Group, iLatinx, Supports Employees and Advocates for Diversity in Life Science

    Many corporations and companies have adopted employee resource groups, or ERGs, into their work cultures to help employees from minority and marginalized backgrounds feel welcome and to provide career support and development.
    Illumina Introduces Multiple Breakthrough Sequencing Innovations at Inaugural Genomics Forum Image

    POSTED 

    10-04-22

    Illumina Introduces Multiple Breakthrough Sequencing Innovations at Inaugural Genomics Forum

    Illumina, a global leader in DNA sequencing and array-based technologies, today announced multiple breakthrough sequencing innovations at its inaugural Illumina Genomics Forum:
    Illumina Unveils Revolutionary NovaSeq X Series To Rapidly Accelerate Genomic Discoveries and Improve Human Health Image

    POSTED 

    10-03-22

    Illumina Unveils Revolutionary NovaSeq X Series To Rapidly Accelerate Genomic Discoveries and Improve Human Health

    llumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced the launch of the NovaSeq™ X Series
    How Comprehensive Genomic Profiling Is Helping Cancer Patients Today Image

    POSTED 

    09-26-22

    How Comprehensive Genomic Profiling Is Helping Cancer Patients Today

    The European Society of Medical Oncology (ESMO) annual congress convened earlier this month in Paris, where, Illumina presented key abstracts demonstrating the clinical utility of comprehensive genomic profiling (CGP). CGP is a next-generation sequencing (NGS) approach that uses a single test to ass...
    Illumina Grant Boosts Climate Action and Job Training Image

    POSTED 

    09-23-22

    Illumina Grant Boosts Climate Action and Job Training

    As part of Illumina’s long-term commitment to sustainability, the Illumina Corporate Foundation made a one-year, $500,000 grant to support GRID Alternatives (Generating Renewable Ideas and Development Alternatives), a nonprofit committed to increasing access to renewable energy and training people f...
    Illumina Accelerator Invests in the Fifth Global Funding Cycle of Startups Advancing Breakthrough Therapeutics, Diagnostics, Women's Health, and Sustainable Agriculture Applications Image

    POSTED 

    09-15-22

    Illumina Accelerator Invests in the Fifth Global Funding Cycle of Startups Advancing Breakthrough Therapeutics, Diagnostics, Women's Health, and Sustainable Agriculture Applications

    Illumina, Inc. today announced that it has invested in six genomics startups for the fifth global funding cycle of Illumina Accelerator in the San Francisco Bay Area and Cambridge, UK.
    Illumina Genomics Forum To Feature Diverse Lineup of Visionary Global Leaders Image

    POSTED 

    09-13-22

    Illumina Genomics Forum To Feature Diverse Lineup of Visionary Global Leaders

    Illumina, a global leader in DNA sequencing and array-based technologies, announced the release of the full agenda for its inaugural Illumina Genomics Forum.
    Delivering the Future of Diagnostics and Precision Oncology Image

    POSTED 

    09-12-22

    Delivering the Future of Diagnostics and Precision Oncology

    At the 34th European Congress of Pathology (ECP) in Basel, Switzerland, September 3 to 7, 2022, pathologists from more than 100 countries will convene to share and gain insights on advancements in their field.
    Latest Research at ESMO Congress 2022 Showcases the Impact of Comprehensive Genomic Profiling for Cancer Patients Image

    POSTED 

    09-08-22

    Latest Research at ESMO Congress 2022 Showcases the Impact of Comprehensive Genomic Profiling for Cancer Patients

    Illumina a global leader in DNA sequencing and array-based technologies, announced the upcoming presentation of multiple oncology research abstracts at this year’s European Society of Medical Oncology (ESMO) annual meeting, September 9–13 in Paris.
    Illumina Genomics Forum To Feature Tennis Legend Chris Evert on the Role Genomics Played in Her Cancer Fight Image

    POSTED 

    09-05-22

    Illumina Genomics Forum To Feature Tennis Legend Chris Evert on the Role Genomics Played in Her Cancer Fight

    Illumina, a global leader in DNA sequencing and array-based technologies, today announced that it will feature International Tennis Hall of Fame member Chris Evert as a special guest at its inaugural Illumina Genomics Forum (IGF) on October 1.
    Illumina logo

    Illumina

    Illumina

    Join today and get the latest delivered to your inbox